pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences is a pharma organization headquartered in Hayward, USA. It trades on NYSE under ticker RCUS. Primary therapeutic focus areas include Advanced Cancer, Non-small Cell Lung Cancer, Metastatic Clear Cell Re
3928 Point Eden Way, Hayward, California 94545, US HQ
2015 Founded
655 Employees
Public company Type
RCUS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
ARC-20
Phase 1 · other · Solid Tumors, Clear Cell Renal Cell Carcinoma
ARC-20 for Solid Tumors, Clear Cell Renal Cell Carcinoma is a Phase 1 program (other) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Internal code ARC-20
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Arcus Biosciences
- Phase
- Phase 1
- Modality
- other
- Indication
- Solid Tumors, Clear Cell Renal Cell Carcinoma
- Status
- active
- Trials
- 1